ReviewCurrent opinion in organ transplantation2026
Xenotransplantation and the organ shortage: evaluating policy priorities.
Review in Current opinion in organ transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewXenotransplantation has emerged as a popular potential solution for increasing organ supply, but it comes with formidable public health risks and ethical harms. The purpose of this review is to evaluate xenotransplantation and other strategies for addressing the organ shortage, pointing toward the most promising policy priorities. RECENT
findingsAdvances in genetic engineering, paired with increasing financial support, have positioned xenotransplantation in its first ever clinical trials. Rejection remains a formidable challenge, and caution prevails as the full breadth of zoonotic infectious potential remains to be determined. Meanwhile, strategies have been implemented around the world to bolster allotransplant organ supply and practices and to better treat chronic diseases to reduce demand for organs. SUMMARY: With more support and broader global adoption, these alternative strategies can address the organ shortage more effectively, safely, and ethically than xenotransplantation and should be prioritized by policymakers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.